INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $19,299,000 | +128.4% | 344,868 | +111.2% | 0.70% | +116.8% |
Q2 2022 | $8,451,000 | -59.6% | 163,280 | -43.3% | 0.32% | -58.8% |
Q1 2022 | $20,922,000 | -0.7% | 287,909 | +61.5% | 0.78% | +9.1% |
Q4 2021 | $21,073,000 | -11.9% | 178,222 | 0.0% | 0.72% | +2.0% |
Q3 2021 | $23,908,000 | -43.9% | 178,222 | -32.3% | 0.70% | -47.3% |
Q2 2021 | $42,618,000 | +86.9% | 263,222 | -7.3% | 1.34% | +91.8% |
Q1 2021 | $22,801,000 | – | 284,101 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |